Examining the Use of Osmolality within Viral Vector Manufacturing

Life Sciences, Pharmaceutical, Cell and Gene Therapy,
  • Tuesday, June 28, 2022

Osmolality, a measure of solute concentration, can have many applications throughout the entirety of the cell and gene therapy process. Low yield, the quality of product and the efficiency of the overall workflow are three current pain points for scientists within viral vector production and manufacturing. Increasing the manufacturing capacity, improving the production yields and the improvement of the supply chain logistics, can make these therapies accessible to larger patient populations, with a focus on a sustainable cost. So, what is the key to improvement in all areas? The answer being the implementation of a high-quality process design and the inclusion of process parameters to ensure robustness and reproducibility at all points within the workflow. In this webinar, the featured speaker will examine the use of osmolality within viral vector manufacturing.

Join this webinar to take a look at the control of osmolality throughout the viral vector workflow and what this may mean for future process improvement within the field.


Kendal Studd, Advanced Instruments

Kendal Studd, Scientific Support Specialist, Advanced Instruments

Kendal specializes in advancing novel osmolality applications within the biopharma industry. She is an experienced scientist with a demonstrated history of working in the biotechnology industry alongside sterilizing grade filters and pharmaceuticals. She graduated from the University of Portsmouth with Distinction in a research Masters’ degree looking at DNA extraction and amplification via PCR.

Message Presenter

Who Should Attend?

Senior professionals who are:

  • Viral Vector Scientists and Managers
  • Cell & Gene Therapy Viral Vector Space
  • Those working with Adeno Associated Virus (AAV)
  • Those working with Lentivirus
  • Process Development
  • Upstream and Downstream Workflows
  • Group Leaders
  • Team Leaders
  • Scientists
  • Process Engineers

What You Will Learn

Attendees will learn:

How modulating osmolality in the early stages of AAV1 (Adeno-Associated Virus Serotype 1) upstream manufacturing can result in improved outcomes such as overall yield, quality, reduced manufacturing costs and improved efficiencies.

Xtalks Partner

Advanced Instruments

Advanced Instruments is a global company offering a novel portfolio of analytical tools including, OsmoTECH®, a robust line of micro-osmometers to support bioprocessing and quality control (QC), and Solentim, a portfolio of best in class imaging and single-cell deposition technologies for cell line development workflows and assurance of clonality for regulatory bodies.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account